![]()
BRS6-1-3 - Insulin Sensitivity & Glucose Disposal
1. Mission & Overview
Mission
Sustain insulin-sensitive glucose disposal so post-meal glucose clears efficiently without prolonged metabolic strain.
Intervention Dominance: Diet-Supported — Lifestyle Levers
- Regular aerobic activity (studied training)
Overview
Insulin helps tissues take up and store circulating glucose after a meal. The effectiveness of that response depends on cellular signalling and the condition of muscle, liver and fat tissue. Exercise training can improve measured insulin action even without weight loss. Magnesium also participates in insulin-receptor function, with deficiency experiments showing impaired action. These routes concern the capacity to handle glucose already available in the circulation. Kirwan et al. (2009) [6]; Suárez et al. (1995) [7]; Magkos et al. (2016) [8]
- Benefits: Improved insulin-responsive disposal reduces the metabolic burden of elevated circulating glucose in the studied populations. Kirwan et al. (2009) [6]
- Implementation Notes: Regular aerobic activity has measured insulin-action evidence; magnesium adequacy is a separate capacity requirement. Kirwan et al. (2009) [6]; Suárez et al. (1995) [7]; Magkos et al. (2016) [8]
- Biological Relevance: A lower glucose excursion alone does not reveal whether insulin sensitivity improved.
2. Primary Biological Effects
- A seven-day exercise study found improved insulin sensitivity and responsiveness of glucose disposal. Kirwan et al. (2009) [6]
- Magnesium depletion impaired insulin-receptor kinase activity and insulin-mediated muscle uptake in rats. Suárez et al. (1995) [7]
- Moderate diet-induced weight loss improved multi-organ insulin sensitivity in adults with obesity. Magkos et al. (2016) [8]
3. Intervention Levers
-
Resistant starch
-
Magnesium
Magnesium’s insulin-receptor capacity role is disclosed with its independently admitted Magnesium requirement. It is referenced here without reprinting the same five atoms. No other separately adjudicated biochemical requirement is added.
No mapping established.
-
Conditional oral arginine supplementation in the tested type-2-diabetes protocol
-
Diet-induced weight reduction when excess adiposity is relevant
4. Mechanistic Basis
Summary
A seven-day exercise study found improved insulin sensitivity and responsiveness of glucose disposal. Kirwan et al. (2009) [6]
Biological process
Clamp/tracer measurements separate peripheral uptake from hepatic production more directly than meal glucose alone. Kirwan et al. (2009) [6]
Mechanism Boundary
A lower glucose excursion alone does not reveal whether insulin sensitivity improved. This assessment preserves each source’s measured endpoint; the Mission describes the biological job and does not assert that every tested lever achieved the entire Mission.
Integration
This PM contributes its specified process to BRS6(FM1). Shared fuels, nutrient lists and correlated markers do not merge distinct biological jobs or establish the integrated outcome.
4.1 Scientific Findings (5)
Summary
Clamp/tracer exercise evidence supports disposal. Magnesium-deficiency experiments support capacity, not universal benefit from supplements. Weight-loss evidence separates improved insulin action from changes in adipose inflammation. Kirwan et al. (2009) [6]; Suárez et al. (1995) [7]; Magkos et al. (2016) [8]
Supports Lifestyle Lever: Regular aerobic activity (studied training)
A seven-day exercise study found improved insulin sensitivity and responsiveness of glucose disposal.
What this means
Clamp/tracer measurements separate peripheral uptake from hepatic production more directly than meal glucose alone.
Evidence confidence: Not yet scored
Finding ID: PM3-F1
Finding Statement: A seven-day exercise study found improved insulin sensitivity and responsiveness of glucose disposal.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Clamp/tracer measurements separate peripheral uptake from hepatic production more directly than meal glucose alone.
Synthesis Limitations: Short small study in type 2 diabetes; contribution of the last exercise bout remains relevant.
Evidence Considered:
- Study
- Seven-day vigorous aerobic training in type 2 diabetes, clamp and glucose tracer.
- Population
- Seven-day vigorous aerobic training in type 2 diabetes, clamp and glucose tracer.
- Result
- Peripheral insulin-responsive uptake improved; hepatic suppression was assessed separately.
- Effect / Magnitude
- Only source-extracted comparisons retained; no pooled benefit estimate.
- Evidence Summary
- Peripheral insulin-responsive uptake improved; hepatic suppression was assessed separately.
- Limitations
- Do not extrapolate the exact exercise prescription to everyone.
- Evidence Source
- Bounded external search
- Reference
- [6]
Connected / Supportive Evidence:
- Mikus et al. (2012) [1]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: The attached source is contextual. No separately extracted mission-specific intermediary or intervention endpoint justifies a new requirement, KC admission or phenome rating from this source.
- Colberg et al. (2016) [2]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: The attached source is contextual. No separately extracted mission-specific intermediary or intervention endpoint justifies a new requirement, KC admission or phenome rating from this source.
- Reynolds et al. (2019) [3]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: Dietary fibre/wholegrain review; supports context, not every named preparation or one isolated constituent mechanism.
- Di Girolamo et al. (2022) [4]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: The attached source is contextual. No separately extracted mission-specific intermediary or intervention endpoint justifies a new requirement, KC admission or phenome rating from this source.
- Marcelli et al. (2025) [5]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: The attached source is contextual. No separately extracted mission-specific intermediary or intervention endpoint justifies a new requirement, KC admission or phenome rating from this source.
Magnesium depletion impaired insulin-receptor kinase activity and insulin-mediated muscle uptake in rats.
What this means
An actual dietary-depletion chain connects magnesium availability to signalling and disposal.
Evidence confidence: Not yet scored
Finding ID: PM3-F2
Finding Statement: Magnesium depletion impaired insulin-receptor kinase activity and insulin-mediated muscle uptake in rats.
Synthesised Evidence Confidence: Not yet scored
Synthesis: An actual dietary-depletion chain connects magnesium availability to signalling and disposal.
Synthesis Limitations: Animal dietary depletion does not define a human intake threshold or enhancement above adequacy.
Evidence Considered:
- Study
- Four-day low-magnesium diet, rat muscle perfusion and purified receptor assays.
- Population
- Four-day low-magnesium diet, rat muscle perfusion and purified receptor assays.
- Result
- Receptor autophosphorylation and submaximal insulin-stimulated uptake were impaired.
- Effect / Magnitude
- Only source-extracted comparisons retained; no pooled benefit estimate.
- Evidence Summary
- Receptor autophosphorylation and submaximal insulin-stimulated uptake were impaired.
- Limitations
- Animal depletion and biochemical activity, not human supplementation efficacy.
- Evidence Source
- Bounded external search
- Reference
- [7]
Supports SOP: Diet-induced weight reduction when excess adiposity is relevant
Moderate diet-induced weight loss improved multi-organ insulin sensitivity in adults with obesity.
What this means
Insulin action can improve before the measured inflammatory markers change.
Evidence confidence: Not yet scored
Finding ID: PM3-F3
Finding Statement: Moderate diet-induced weight loss improved multi-organ insulin sensitivity in adults with obesity.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Insulin action can improve before the measured inflammatory markers change.
Synthesis Limitations: The later progressive subgroup was small; no assumption of universal weight-loss need.
Evidence Considered:
- Study
- Randomized weight-maintenance versus diet-induced weight-loss study, clamps and adipose sampling.
- Population
- Randomized weight-maintenance versus diet-induced weight-loss study, clamps and adipose sampling.
- Result
- About 5% loss improved insulin sensitivity without reduced measured adipose inflammation.
- Effect / Magnitude
- Only source-extracted comparisons retained; no pooled benefit estimate.
- Evidence Summary
- About 5% loss improved insulin sensitivity without reduced measured adipose inflammation.
- Limitations
- Later larger losses were not a new independently randomized dose comparison.
- Evidence Source
- Bounded external search
- Reference
- [8]
Supports SOP: Conditional oral arginine supplementation in the tested type-2-diabetes protocol
Oral arginine improved clamp-measured glucose disposal in the small type-2-diabetes comparison.
What this means
Incomplete normalisation; small selected clinical population. cGMP change does not isolate causal NO mediation. The 9 g/day supplement protocol is not equivalent to arginine-containing food.
Evidence confidence: Not yet scored
Finding ID: PM3-F4
Finding Statement: Oral arginine improved clamp-measured glucose disposal in the small type-2-diabetes comparison.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Oral arginine improved clamp-measured glucose disposal in the small type-2-diabetes comparison.
Synthesis Limitations: Incomplete normalisation; small selected clinical population. cGMP change does not isolate causal NO mediation. The 9 g/day supplement protocol is not equivalent to arginine-containing food.
Evidence Considered:
- Study
- Usual diet then placebo; intervention group received 3 g arginine three times daily for one month.
- Population
- Twelve lean adults with type 2 diabetes; double-blind study with random allocation into two groups.
- Result
- Oral arginine improved clamp-measured glucose disposal in the small type-2-diabetes comparison.
- Effect / Magnitude
- Only the specified source-level endpoint is assessed; no pooled effect or food-dose estimate is inferred.
- Evidence Summary
- Euglycaemic-hyperinsulinaemic clamp with glucose tracer; endogenous glucose production and cGMP.
- Limitations
- Incomplete normalisation; small selected clinical population. cGMP change does not isolate causal NO mediation. The 9 g/day supplement protocol is not equivalent to arginine-containing food.
- Evidence Source
- Bounded external search
- Reference
- [9]
Evidence Dependency:
- The source-specific observations support different links; food composition, biochemical identity, intervention exposure and clinical outcomes are not interchangeable. Reuse across PMs is not independent replication.
A small placebo-controlled human supplementation study found higher clamp insulin sensitivity and forearm glucose clearance; a later type-2-diabetes trial did not establish a clamp improvement.
What this means
Defined oral resistant-starch supplementation modulated clamp-measured insulin sensitivity and post-meal forearm glucose clearance in a small human study.
Evidence confidence: Not yet scored
Finding ID: PM3-F5
Finding Statement: A small placebo-controlled human supplementation study found higher clamp insulin sensitivity and forearm glucose clearance; a later type-2-diabetes trial did not establish a clamp improvement.
Synthesised Evidence Confidence: Not yet scored
Synthesis: A small placebo-controlled human supplementation study found higher clamp insulin sensitivity and forearm glucose clearance; a later type-2-diabetes trial did not establish a clamp improvement.
Synthesis Limitations: Preparation-, dose- and population-specific. The positive study used 30 g/day for four weeks in ten healthy participants; this is not an effective whole-food dose. Preserve the later 40 g/day type-2-diabetes null. SCFA mediation and universal benefit are unestablished; no brain or ADHD inference. Numerical SEC remains pending full-method appraisal; no factor is forced.
Evidence Considered:
- Study
- Human resistant-starch supplementation with clamp and tissue metabolic endpoints, contrasted with a later type-2-diabetes trial.
- Population
- Ten healthy participants in the positive study; 17 adults with type 2 diabetes in the later crossover.
- Result
- Clamp insulin sensitivity and post-meal forearm clearance were higher following the tested resistant-starch supplementation.
- Effect / Magnitude
- No additional magnitude inferred.
- Evidence Summary
- Clamp insulin sensitivity and post-meal forearm clearance were higher following the tested resistant-starch supplementation.
- Limitations
- Preparation-, dose- and population-specific. The positive study used 30 g/day for four weeks in ten healthy participants; this is not an effective whole-food dose. Preserve the later 40 g/day type-2-diabetes null. SCFA mediation and universal benefit are unestablished; no brain or ADHD inference.
- Evidence Source
- Bounded external search
- Reference
- [10]
- Study
- Human resistant-starch supplementation with clamp and tissue metabolic endpoints, contrasted with a later type-2-diabetes trial.
- Population
- Ten healthy participants in the positive study; 17 adults with type 2 diabetes in the later crossover.
- Result
- The tested 40 g/day resistant-starch intervention did not establish improved clamp insulin sensitivity in type 2 diabetes.
- Effect / Magnitude
- No additional magnitude inferred.
- Evidence Summary
- The tested 40 g/day resistant-starch intervention did not establish improved clamp insulin sensitivity in type 2 diabetes.
- Limitations
- Preparation-, dose- and population-specific. The positive study used 30 g/day for four weeks in ten healthy participants; this is not an effective whole-food dose. Preserve the later 40 g/day type-2-diabetes null. SCFA mediation and universal benefit are unestablished; no brain or ADHD inference.
- Evidence Source
- Bounded external search
- Reference
- [11]
5. BRS Pathways and Connections
5.1 BRS Pathways
No newly adjudicated BRS pathway is established by this assessment.
5.2 Cross-BRS Mechanism Relationships
- BRS-X(Circadian-FM1-PM2) — Feeding-Time Circadian Synchronisation — insulin/IGF-1 can communicate feeding time to peripheral clocks in model systems (Crosby et al., 2019); human circadian misalignment altered glucose/insulin responses (Scheer et al., 2009). This separates clock entrainment from glucose disposal and does not establish ADHD-specific mediation.
No downstream mapping is inherited from a shared nutrient or KC candidate.
5.3 Local BRS Mechanism Relationships
PM1 addresses entry and PM2 addresses the glucose profile; insulin-sensitive disposal is a distinct measured job.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
No direct functional outcome relationship currently mapped.
Stage 2A/2B dietary-target assessment — 23 October 2026
ENRICHED. Insulin-sensitive disposal measured separately from glucose appearance.
Admit the tested supplement protocol under SOPs; the clamp directly assessed disposal. Do not admit arginine-rich food efficacy or assert that cGMP proves NO mediation. Existing magnesium and exercise/weight-loss records remain unchanged.
New implementation: 0 dietary-input admissions (0 completed Unset candidates), 1 practices, 0 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.
Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.
8. References
- [1] Mikus et al. (2012) — Glycaemic Control Is Improved by 7 Days of Aerobic Exercise Training in
- [2] Colberg et al. (2016) — A Position Statement of the American Diabetes Association.
- [3] Reynolds et al. (2019) — A Series of Systematic Reviews and Meta-analyses.
- [4] Di Girolamo et al. (2022) — Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult
- [5] Marcelli et al. (2025) — Insights Into Shared Mechanisms and Clinical Implications
- [6] Kirwan et al. (2009) — Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus
- [7] Suárez et al. (1995) — Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats
- [8] Magkos et al. (2016) — Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity
- [9] Piatti et al. (2001) — Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients.
- [10] Robertson et al. (2005) — Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism
- [11] Bodinham et al. (2014) — Efficacy of increased resistant starch consumption in human type 2 diabetes
Foods supply the named dietary input. They are not shown as containing the downstream metabolite. Conversion evidence does not establish a new downstream PM admission, effective dose or equivalent food intervention.
Resistant starch → Microbial resistant-starch utilisation and community cross-feeding can contribute to butyrate formation → Butyrate
BRS6-FM1-PM3: Sustain insulin-sensitive glucose disposal so post-meal glucose clears efficiently without prolonged metabolic strain.
Existing admission: Type B / direct; versioned-assessment. Production context for an already admitted substrate; no new metabolite-to-PM relationship is admitted.
Preparation-, dose- and population-specific. The positive study used 30 g/day for four weeks in ten healthy participants; this is not an effective whole-food dose. Preserve the later 40 g/day type-2-diabetes null. SCFA mediation and universal benefit are unestablished; no brain or ADHD inference.
- Bananas — supplies Resistant starch; verified; Green/unripe; cultivar and ripening state matter. Cavendish and plantain bananas
Composition provenance
Gao et al., Postharvest Biology and Technology 2016
Direct starch analyses examined resistant-starch decline during ripening in two cultivars.
- Black Beans — supplies Resistant starch; verified; Cooked; cooking duration and cooling protocol remain study-specific. Cooked black beans
Composition provenance
Fabbri et al., NFS Journal 2016
The study directly assayed resistant starch in cooked black beans, pinto beans and chickpeas.
- Chickpeas — supplies Resistant starch; verified; Cooked; cooking duration and cooling protocol remain study-specific. Cooked chickpeas
Composition provenance
Fabbri et al., NFS Journal 2016
The study directly assayed resistant starch in cooked black beans, pinto beans and chickpeas.
- Potatoes — supplies Resistant starch; verified; Baked or boiled, then chilled to 4°C; distinguish reheated material. Yukon Gold, Dark Red Norland and Russet Burbank potatoes
Composition provenance
Raatz et al., Food Chemistry 2016
Resistant starch was measured by cooking method and service temperature.
Defined starch preparations and microbial contexts; no conversion yield, guaranteed butyrate response from bananas, potatoes or legumes, or established PM1 tight-junction mediation. Ruminococcus bromii degradation is not itself proof of butyrate production.
Dependencies: Accessible resistant-starch preparation reaching the colon; Capable primary degraders and butyrate-producing community members; Suitable anaerobic fermentation environment